Multiple Myeloma Flashcards
(49 cards)
Haemapoietic stem cell seperates into what?
Lymphoid and myeloid stem cell, NK cells
Lymphoid stem cell gives us what
T and B lymphocyte
Myeloid stem cells give us what
Eryhtrocyte
Platelets
Mast cell
Eosinophil
Polymorph
monocyte
osteoclast
Different types of leukaemia
Acute myeloid leukaemia
Acute lymphoblastic leukaemia
Chronic myeloid leukaemia
Chronic lymphocytic leukaemia
Acute leukaemia
– primitive early cells – high proliferative rate – chemo targets cell in division
Chronic leukaemia
lower proliferative rate – insensitive to chemo
What is a myeloma?
Bone marrow cancer
Cancer of differentiated B-lymphocytes, known as plasma cells
What is a multiple myeloma?
is where the myeloma affects multiple areas of the body.
Features of multiple myelomas
- The accumulation of malignant plasma cells in the bone marrow leading to progressive bone marrow failure
- The production of a characteristic paraprotein
- Kidney failure
- Destructive bone disease and hypercalcaemia
What are multiple myelomas assosciated with?
devastating osteolytic bone disease charcterised by:
Osteoporosis
Pepper pot skull
Punch through lesions
Mechanisms include an increase in bone resorption, decrease in bone formation and an uncoupling of resorption and formation leading to rapid bone loss.
What is the pneumonic for melanoma signs and symptoms?
SPIKEY OLD CRAB
C
Calcium
Ca>0.25mmol/l above upper limit of normal or >2.75mmol/l
R
Renal
renal impairment, creatinine>173mmol
Pathogenesis and treatment of renal failiure in multiple myeloma
A
– anaemia
2g <NR or <10g/dl
B
Bone
lytic lesions, osteoporosis compression, spinal cord compression
Problem with myeloma
myeloma remains almost always incurable; it is a remitting, relapsing condition which inexorably progresses to refractory disease and death
Multiple myeloma incidence
10% of all haematological cancers; overall, the second commonest haematological cancer after non-Hodgkins lymphoma
incidence 60-70 per million; approx 4,000 new cases of myeloma per anum in the UK
Median age diagnosis 70 years
Survival ranges from few months to 20 years sometimes
Monoclonal gammopathy of undetermined significance (MGUS)
<30g/dl, <10% plasma cells in the bone marrow, no related organ or tissue impairment (ROTI), no evidence of amyloid or other lymphoproliferative disorder (LPD)
an excess of a single type of antibody or antibody components without other features of myeloma or cancer.
often an incidental finding in an otherwise healthy person - significance unclear.
It may progress to myeloma and patients are often followed up routinely to monitor for progression.
Smouldering myeloma
> 30g/l and/or >10% plasma cells in BM, but no ROTI
20% risk per year of progression in first year, then diminishes to about 5% per year after 5 years and then stabilises
progression of MGUS with higher levels of antibodies or antibody components.
premalignant and more likely to progress to myeloma than MGUS.
Waldenstrom’s macroglobulinemia is a type of smouldering myeloma where there is excessive IgM specifically.
Symptomatic myeloma
diagnostic criteria as evidence of related organ or tissue impairment (ROTI) or amyloid
Is MGUS common?
Yes
present in 3% people aged 50, 5% aged 70 – 1% risk per year of progression; majority of cases of MM present de novo but now recognised that most have had a preceding MGUS phase
Pathophysiology of myeloma
accumulation of malignancy plasma cells in the bone marrow> production of paraprotein [increased amount of plasma protein]> increased proteinuria [protein in urine]> renal disease + destruction bone disease
Pathophysiology of myeloma and antibodies:
When you measure the immunoglobulins in a patient with myeloma, one of those types will be significantly abundant.
This single type of antibody that is produced by all the identical cancerous plasma cells can be called a monoclonal paraprotein. This means a single type of abnormal protein.
How does the destructive bone disease happen?
increased plasma cells 🡪 osteoclasts 🡪 increased bone degraded